The rising global focus on well-being, coupled with a growing elderly population and increasing pressure on service industries to deliver empathetic and efficient interactions, drives demand for this technology. Companies are seeking non-invasive methods to monitor user states and enhance communication quality, moving beyond traditional metrics. This patent offers a competitive edge by providing a robust, real-time solution for dialogue support in an era where human connection is paramount but resources are constrained.
Provides high-precision dialogue support by directly determining dialogue continuity from heart rate signal fluctuations, eliminating the need for complex biosignal correlation analysis.
Integrates into existing systems at low cost, leveraging general-purpose heart rate sensors and software to avoid significant capital expenditure.
Demonstrates high originality, having overcome two prior art references cited by the examiner, confirming its distinct technical superiority.
This patent protects a unique dialogue support system that overcomes two prior art references, demonstrating strong technical superiority and claim stability. With 6 claims, it covers a broad technical scope, meticulously drafted by multiple agents, providing a robust foundation for licensees to confidently pursue market opportunities.
This patent primarily covers heart rate signal analysis for dialogue continuity. White space exists for integrating other biosignals (e.g., skin conductance, EEG) or for advanced natural language processing to analyze dialogue content and sentiment.
Introducing this technology in elder care facilities could reduce staff workload by 1 hour/day per staff, estimated to save ~$50K/year (AI est.) in labor costs per facility. For 5 medium-sized facilities (50 staff each), this could result in a total annual cost reduction of ~$250K (AI est.).
X: Dialogue Continuity Support Accuracy
Y: Ease of Implementation